These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19244047)

  • 1. Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer.
    Shukla-Dave A; Hricak H; Ishill NM; Moskowitz CS; Drobnjak M; Reuter VE; Zakian KL; Scardino PT; Cordon-Cardo C
    Radiology; 2009 Mar; 250(3):803-12. PubMed ID: 19244047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles.
    Shukla-Dave A; Hricak H; Ishill N; Moskowitz CS; Drobnjak M; Reuter VE; Zakian KL; Scardino PT; Cordon-Cardo C
    Clin Cancer Res; 2009 Jun; 15(11):3842-9. PubMed ID: 19435838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
    Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
    Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging.
    Zhang J; Hricak H; Shukla-Dave A; Akin O; Ishill NM; Carlino LJ; Reuter VE; Eastham JA
    Radiology; 2009 Nov; 253(2):425-34. PubMed ID: 19864529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study.
    Weinreb JC; Blume JD; Coakley FV; Wheeler TM; Cormack JB; Sotto CK; Cho H; Kawashima A; Tempany-Afdhal CM; Macura KJ; Rosen M; Gerst SR; Kurhanewicz J
    Radiology; 2009 Apr; 251(1):122-33. PubMed ID: 19332850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines.
    Shukla-Dave A; Hricak H; Moskowitz C; Ishill N; Akin O; Kuroiwa K; Spector J; Kumar M; Reuter VE; Koutcher JA; Zakian KL
    Radiology; 2007 Nov; 245(2):499-506. PubMed ID: 17890357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume.
    Mazaheri Y; Hricak H; Fine SW; Akin O; Shukla-Dave A; Ishill NM; Moskowitz CS; Grater JE; Reuter VE; Zakian KL; Touijer KA; Koutcher JA
    Radiology; 2009 Aug; 252(2):449-57. PubMed ID: 19703883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection.
    Westphalen AC; Coakley FV; Roach M; McCulloch CE; Kurhanewicz J
    Radiology; 2010 Aug; 256(2):485-92. PubMed ID: 20551184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer.
    Shukla-Dave A; Hricak H; Akin O; Yu C; Zakian KL; Udo K; Scardino PT; Eastham J; Kattan MW
    BJU Int; 2012 May; 109(9):1315-22. PubMed ID: 21933336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation.
    Turkbey B; Pinto PA; Mani H; Bernardo M; Pang Y; McKinney YL; Khurana K; Ravizzini GC; Albert PS; Merino MJ; Choyke PL
    Radiology; 2010 Apr; 255(1):89-99. PubMed ID: 20308447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms.
    Wang L; Hricak H; Kattan MW; Chen HN; Scardino PT; Kuroiwa K
    Radiology; 2006 Feb; 238(2):597-603. PubMed ID: 16344335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer: endorectal MR imaging and MR spectroscopic imaging--distinction of true-positive results from chance-detected lesions.
    Hom JJ; Coakley FV; Simko JP; Qayyum A; Lu Y; Schmitt L; Carroll PR; Kurhanewicz J
    Radiology; 2006 Jan; 238(1):192-9. PubMed ID: 16373767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging.
    Westphalen AC; Coakley FV; Qayyum A; Swanson M; Simko JP; Lu Y; Zhao S; Carroll PR; Yeh BM; Kurhanewicz J
    Radiology; 2008 Jan; 246(1):177-84. PubMed ID: 18024434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience.
    Coakley FV; Teh HS; Qayyum A; Swanson MG; Lu Y; Roach M; Pickett B; Shinohara K; Vigneron DB; Kurhanewicz J
    Radiology; 2004 Nov; 233(2):441-8. PubMed ID: 15375223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system.
    Jung JA; Coakley FV; Vigneron DB; Swanson MG; Qayyum A; Weinberg V; Jones KD; Carroll PR; Kurhanewicz J
    Radiology; 2004 Dec; 233(3):701-8. PubMed ID: 15564406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience.
    Prando A; Kurhanewicz J; Borges AP; Oliveira EM; Figueiredo E
    Radiology; 2005 Sep; 236(3):903-10. PubMed ID: 16118169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T.
    Kobus T; Vos PC; Hambrock T; De Rooij M; Hulsbergen-Van de Kaa CA; Barentsz JO; Heerschap A; Scheenen TW
    Radiology; 2012 Nov; 265(2):457-67. PubMed ID: 22843767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy.
    Zakian KL; Sircar K; Hricak H; Chen HN; Shukla-Dave A; Eberhardt S; Muruganandham M; Ebora L; Kattan MW; Reuter VE; Scardino PT; Koutcher JA
    Radiology; 2005 Mar; 234(3):804-14. PubMed ID: 15734935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging.
    Fütterer JJ; Heijmink SW; Scheenen TW; Veltman J; Huisman HJ; Vos P; Hulsbergen-Van de Kaa CA; Witjes JA; Krabbe PF; Heerschap A; Barentsz JO
    Radiology; 2006 Nov; 241(2):449-58. PubMed ID: 16966484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging.
    Akin O; Sala E; Moskowitz CS; Kuroiwa K; Ishill NM; Pucar D; Scardino PT; Hricak H
    Radiology; 2006 Jun; 239(3):784-92. PubMed ID: 16569788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.